Literature DB >> 9300698

Alternative peptide binding motifs of Qa-2 class Ib molecules define rules for binding of self and nonself peptides.

P Tabaczewski1, E Chiang, M Henson, I Stroynowski.   

Abstract

Studies of naturally processed peptides eluted from membrane-bound and soluble isoforms of murine class Ib Qa-2 molecules determined several features of these ligands, such as the conserved nonameric length and the preferred usage of specific residues at four to six of nine peptide positions. The structural information derived from these studies proved insufficient to distinguish between two interpretations: 1) that Qa-2 are peptide receptors of higher stringency than ordinary class I molecules, and 2) that Qa-2 molecules, like classical class I Ags, bind diverse arrays of peptides. We have addressed this issue by a systematic analysis of peptide residues involved in the binding of membrane-bound Qa-2 molecule, MQ9b. The optimal binding of synthetic peptides in vitro occurs at neutral pH. Two dominant anchors are required for peptide binding to MQ9b: His at position 7 and a hydrophobic residue, Leu, Ile, or Phe, at position 9. In addition, one or two auxiliary anchors participate in binding. The identity and the position of the auxiliary anchors differ from peptide to peptide, suggesting that the binding motifs defined from pool sequencing are composed of many superimposed alternative motifs present in individual peptides. The number of anchors used by Qa-2 peptides is similar to that found in ligands of classical class I Ags. Consequently, the Qa-2 are predicted to bind large repertoires of self and nonself peptides. In support of this interpretation we demonstrate that MQ9b binds strongly 5 of 17 motif-positive, pathogen-derived synthetic peptides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300698

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus.

Authors:  Lili Chen; David C Jay; Jared D Fairbanks; Xiao He; Peter E Jensen
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

Review 2.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

3.  Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites.

Authors:  Pierre Lau; Claire Amadou; Hélène Brun; Virginie Rouillon; Fiona McLaren; Anne-France Le Rolle; Margaret Graham; Geoffrey W Butcher; Etienne Joly
Journal:  BMC Immunol       Date:  2003-07-01       Impact factor: 3.615

4.  Taenia crassiceps cysticercosis: immune response in susceptible and resistant BALB/c mouse substrains.

Authors:  Sergio López-Briones; Edmundo Lamoyi; Gladis Fragoso; Mark J Soloski; Edda Sciutto
Journal:  Parasitol Res       Date:  2003-03-12       Impact factor: 2.289

5.  Peptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice.

Authors:  Amelia R Hofstetter; Brian D Evavold; Aron E Lukacher
Journal:  Viral Immunol       Date:  2013-02-01       Impact factor: 2.257

Review 6.  The role of MHC class Ib-restricted T cells during infection.

Authors:  Courtney K Anderson; Laurent Brossay
Journal:  Immunogenetics       Date:  2016-07-01       Impact factor: 2.846

7.  The role of tapasin in MHC class I protein trafficking in embryos and T cells.

Authors:  Paula W Lampton; Carmit Y Goldstein; Carol M Warner
Journal:  J Reprod Immunol       Date:  2007-12-03       Impact factor: 4.054

Review 8.  Immunity to polyomavirus infection: the polyomavirus-mouse model.

Authors:  Phillip A Swanson; Aron E Lukacher; Eva Szomolanyi-Tsuda
Journal:  Semin Cancer Biol       Date:  2009-02-14       Impact factor: 15.707

9.  ERAAP Shapes the Peptidome Associated with Classical and Nonclassical MHC Class I Molecules.

Authors:  Niranjana A Nagarajan; Danielle A de Verteuil; Dev Sriranganadane; Wafaa Yahyaoui; Pierre Thibault; Claude Perreault; Nilabh Shastri
Journal:  J Immunol       Date:  2016-07-01       Impact factor: 5.422

10.  An MHC class Ib-restricted CD8 T cell response confers antiviral immunity.

Authors:  Phillip A Swanson; Christopher D Pack; Annette Hadley; Chyung-Ru Wang; Iwona Stroynowski; Peter E Jensen; Aron E Lukacher
Journal:  J Exp Med       Date:  2008-06-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.